Track topics on Twitter Track topics that are important to you
Technavio’s latest market research report on the global digital blood pressure monitors market provides an analysis of the most important trends expected to impact the market outlook from 2018-2022. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180215006054/en/
Technavio has published a new market research report on the global digital blood pressure monitors market from 2018-2022. (Graphic: Business Wire)
According to Technavio analysts, the global digital blood pressure monitors market will grow at a CAGR of almost 10% during the forecast period. The increasing incidence of hypertension coupled with the geriatric population is a major factor driving the market’s growth.
The blood pressure above 130/80 is considered high and may affect the heart and the kidneys. High blood pressure usually leads to a condition called hypertension that is a significant risk factor responsible for overall mortality rate across the world. Hypertension increases the risk of diseases such as stroke, heart diseases, and kidney failures by putting pressure on the arteries. High blood pressure can also cause harm to the brain by causing a transient ischemic attack, stroke, dementia, and mild cognitive impairment. It also affects the eyes by causing damage to the retina, nerves, sexual dysfunction, bone loss and conditions such as obstructive sleep apnea.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Save more with Technavio. Buy 2 reports and get the third for FREE: View all Technavio’s current offers
In this report, Technavio highlights the growing demand for ambulatory blood pressure monitoring systems as one of the key emerging trends driving the global digital blood pressure monitors market:
Growing demand for ambulatory blood pressure monitoring systems
Ambulatory blood pressure monitors (ABPM) are usually used to diagnose white coat hypertension or masked hypertension. The ambulatory blood pressure monitors are available in compact size, arm based or wrist-based, unique user-friendly features for easy accessibility. Measuring blood pressure through ambulatory blood pressure monitoring systems is a non-invasive method of obtaining blood pressure readings. The procedure assists physicians in obtaining blood pressure profiles during an individual's daily activities.
“Recording of blood pressure profiles gives an estimate of the mean blood pressure and blood pressure variability. The procedure aids in assessing the various patterns of blood pressure behavior such as white coat hypertension, hypertension, hypotension, dipping, and non-dipping. It also helps to monitor the effectiveness of blood pressure medications,” says a senior analyst at Technavio for research on patient monitoring devices.
ABPM is used to diagnose arterial hypertension at home, clinic, and other home care settings. These ABPM systems are available as arm based and wrist-based and are used accordingly as prescribed by the physician. Vendors in this market are designing and manufacturing ABPM systems with advanced technical features that cater to the requirements of the physicians and the patients.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Global digital blood pressure monitors market segmentation
This market research report segments the global digital blood pressure monitorsmarket by product (stand alone and integrated), by end-users (hospitals and clinics, home care, and ASCs), and by geography (the Americas, APAC, and EMEA).
In 2017, hospitals dominated the end-user segment with a market share of more than 47%. This segment also includes the revenue generated by the clinics. Hospitals may be private entities or working under government institutions. This segment was followed by the ASCs and the homecare segment in terms of market share.
In 2017, the global digital blood pressure monitors market was dominated by the Americas, that contributed to a market share of close to 42%. It was followed by EMEA and APAC respectively. North America, especially the US, is the primary revenue contributor in the Americas because of the availability of adequate reimbursements and advancements in healthcare infrastructure. Also, the increasing prevalence of hypertension along with growing geriatric population, sedentary lifestyles, diabetes obesity, and the presence of key vendors in this region will contribute to the market growth in this region.
Big savings with Technavio this February!
Get 20% OFF on all Education Technology reports. This offer is valid only till the 28th of this month.
Celebrate winter sports with 23% OFF on all reports in the Outdoor Gear library (Offer valid from Feb 9-25).
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...